Mean (SD) standardised KOOS scores over the testing period for the glucosamine (G) and placebo (P) group
| Week 0 | Week 4 | Week 8 | Week 12 | |||||
|---|---|---|---|---|---|---|---|---|
| Section of KOOS | G (n=25) | P (n=23) | G (n=25) | P (n=22) | G (n=25) | P (n=23) | G (n=24) | P (n=22) |
| ASignificant main time effect at p=<0.05. | ||||||||
| BSignificant group main effect at p=<0.05. | ||||||||
| CSignificant interaction at p=<0.05. | ||||||||
| *Significant group difference at p=<0.05. | ||||||||
| Pain A B | 55 (11) | 49 (15) | 57 (11) | 54 (13) | 62 (10) | 52 (14) | 60 (11) | 54 (14) |
| Symptoms A | 48 (12) | 41 (12) | 52 (14) | 47 (14) | 55 (14) | 48 (16) | 54 (14) | 50 (15) |
| Activities of daily living A B | 61 (11) | 56 (14) | 64 (12) | 59 (13) | 68 (10) | 58 (15) | 67 (11) | 62 (15) |
| Sport/recreation A | 40 (21) | 46 (23) | 50 (19) | 52 (22) | 55 (19) | 55 (22) | 53 (18) | 46 (21) |
| Knee related quality of life A C | 34 (15) | 27 (13) | 34 (17) | 30 (13) | 40* (17) | 29 (14) | 42* (16) | 32 (15) |
| Total KOOS score A | 53 (11) | 49 (10) | 56 (11) | 53 (11) | 61 (11) | 52 (12) | 60 (11) | 54 (14) |